IAG Cargo's new constant climate centre in Madrid for pharma products
THE cargo handling division of International Airlines Group, IAG Cargo, has inaugurated a new pharmaceutical centre in Madrid dedicated to its constant climate product for transporting time and temperature-sensitive pharmaceutical products
THE cargo handling division of International Airlines Group, IAG Cargo, has inaugurated a new pharmaceutical centre in Madrid dedicated to its constant climate product for transporting time and temperature-sensitive pharmaceutical products.
Work on the new facility began in June 2018 and is the latest addition to IAG Cargo's Madrid hub, which handles over 250,000 tonnes of cargo per year, reports AJOT.
With two dedicated temperature-controlled chambers totalling over 900 square metres, the Good Distribution Practice (GDP) certified facility will allow IAG Cargo to increase the volumes of temperature sensitive pharmaceutical products passing through its Madrid hub, primarily serving the growing Latin American pharmaceuticals market, projected to increase by 9 per cent per year until 2028.
The new centre is operated by an expert team, with shipments loaded onto dedicated airside docks and served by a specialist fleet of refrigerated trucks in order to protect the pharmaceuticals from the cargo terminal to loading onto aircraft.
Constant climate is IAG Cargo's state-of-the-art cold chain product, specially designed for precision management of time and temperature sensitive pharmaceutical products. Trusted by the world's largest pharmaceutical manufacturers, the service is managed via a dedicated team who handle bookings, advise on packaging solutions and ensure shipments meet the strictest of regulatory standards.
Camilo Garcia, director of Sales, Marketing and Products at IAG Cargo, said: 'The opening of this new constant climate centre reflects our continued investment in our infrastructure and operations. Constant climate was the first pharma-only product to the market and last year we shipped over 25,000 tonnes of life-saving medicines and vaccines.
'Good Distribution Practice (GDP) is a critical focus for our Constant climate product as it ensures delivery of medicine to the end-patient in a pure, potent and stable condition.'